Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form Type: S-8 POS

Filing Date: 2024-04-15

View Filing

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form Type: S-8 POS

Filing Date: 2024-04-15

View Filing

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form Type: S-8 POS

Filing Date: 2024-04-15

View Filing

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form Type: S-8 POS

Filing Date: 2024-04-15

View Filing

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form Type: S-8 POS

Filing Date: 2024-04-15

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-04-03

View Filing

NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form Type: NT 10-K

Filing Date: 2024-04-01

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-03-29

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-03-05

View Filing

DEFM14C - Definitive information statement relating to merger or acquisition

Form Type: DEFM14C

Filing Date: 2024-03-05

View Filing